Opportunity
Simpler Grants.gov #RFA-RM-26-004
NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional) Grant Opportunity
Buyer
National Institutes of Health
Posted
December 11, 2025
Respond By
September 04, 2026
Identifier
RFA-RM-26-004
NAICS
541715
This opportunity from the National Institutes of Health (NIH) supports early-career biomedical researchers seeking to launch independent research programs immediately after completing their doctoral or clinical training. - Government Buyer: - National Institutes of Health (NIH), a federal agency - Program Details: - NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional) - Part of the NIH Common Fund's High-Risk, High-Reward Research initiative - Supports independent research in any area of biomedical sciences - Designed for investigators bypassing the traditional post-doctoral period - Eligibility: - Open to higher education institutions, independent school districts, tribal, state, and local governments, nonprofits, small businesses, for-profit organizations, and certain federal agencies - Funding: - Approximately 10 awards expected - Each award is $350,000 (minimum and maximum) - Total program funding is $5,700,000 - Notable Requirements: - No specific OEMs, vendors, or product/service procurements are involved - This is a grant for research support, not a purchase of goods or services
Description
The NIH Director's Early Independence Award supports promising investigators who wish to pursue independent research soon after completing their terminal doctoral degree or post-graduate clinical training, bypassing the traditional post-doctoral period. Applications are accepted in any area within the biomedical sciences. This award is part of the High-Risk, High-Reward Research program of the NIH Common Fund. The program aims to accelerate entry into an independent research career for eligible applicants.